Social News
Written by: Zheng Cuibi
2021-01-16 09:44
Last update date: 2021-01-16 09:44
The new crown pneumonia epidemic continues, and the Hong Kong government has ordered vaccines from different pharmaceutical companies. Among them, China Science and Technology has published effective data in different countries, but has not yet released a complete report, including information on side effects.
Kong Fanyi, a member of the Hong Kong Vaccine Advisory Committee and a clinical professor in the Department of Internal Medicine of the University of Hong Kong, said on a radio program today (16th) that it is speculated that Kexing can release the complete report in a short period of time, and when the report is available, the advisory committee can Complete the approval within two weeks.
He believes that although Coxing's test in Brazil is only 50.38% efficient, it is necessary to rely on the complete report to determine whether the Hong Kong government should continue to buy, because it needs to balance side effects and other issues.
He also said that even if the protection rate of a vaccine is not high, if its side effects are also low, it can be an option, and elderly people who are not highly active can consider it.
Kong Fanyi speculated that Kexing could publish the complete report in a short period of time, and when the report is available, the advisory expert committee can complete the approval within one or two weeks.
(Profile picture)
Kong Fanyi said on the Hong Kong and Taiwan program "Saturday Accountability" that Kexing has only announced an overall effective rate of 50.38%, and experts must wait for the full report to make a judgment.
He explained that the current information does not reflect the efficiency of people of different ages and groups. It is only the data of Brazil. Coxing will integrate its test data in Turkey and Indonesia and publish it in international medical journals. The full report will only be accurate at that time.
He speculated that Kexing can publish the complete report in a short period of time, and when the report is available, the advisory expert committee can complete the approval within one or two weeks.
▼Protection rate side effects of Kexing, BioNTECH Fosun, AstraZeneca ▼
+2
+2
+2
He also pointed out that experts will publish a detailed analysis of vaccines, and citizens can choose different vaccines according to their own circumstances. For example, an elderly person who is bedridden for a long time and goes out less often can choose a vaccine with a relatively low protection rate and low side effects; But an elderly person who is highly active, often travels abroad, and is in good physical condition can consider a vaccine with a high protection rate and relatively high side effects.
According to currently published information, among the three vaccines currently purchased by the Hong Kong government, BioNTech has the highest protection rate, while Kexing has the lowest side effects.
New Crown Vaccine | Expert Committee Liu Zexing: It is difficult to estimate that it will be vaccinated after the lunar new year
New Coronary Pneumonia | Biden Appoints Former Director of FDA to Accelerate Vaccine Promotion Plan
New crown pneumonia | Biden announced to speed up vaccination plan will use national defense production law
01News
New crown pneumonia vaccineNew crown vaccine vaccination
